Systolic Heart Failure Clinical Trial
The purpose of this study is to determine if udenafil improves exercise tolerance in patients with systolic heart failure.
Udenafil (Zydena), a newly developed PDE-5 inhibitor, has been proved to have similar efficacy and safety profile, compared with other PDE-5 inhibitors. Also, laboratory data showed that udenafil inhibits ventricular hypertrophy and fibrosis in rat heart failure model. Based on these results, the investigators hypothesized that udenafil would improve symptom, exercise capacity and hemodynamic status in patients with systolic heart failure. In this 12-week, randomized, double-blind, placebo-controlled trial, patients with systolic heart failure will be enrolled according to the eligibility criteria. After randomization, study participants will be assigned to receive either 50mg of udenafil or placebo two times a day for 4 weeks, and then the dosage will be doubled to 100mg two times a day for next 8 weeks. Participants will attend study visits at baseline and weeks 4 and 12. Physical examination, medical history review, blood sample collection and electrocardiogram will be conducted on each study visits. At baseline and week 12, participants will undergo cardiopulmonary exercise test and exercise echocardiography. At every study visits,researchers will collect health information. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02026102 -
A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)
|
N/A | |
Active, not recruiting |
NCT00949676 -
DECIDE-HF: Heart Rate Variability in Heart Failure Patients
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Recruiting |
NCT05230732 -
Neuromodulation of Inflammation and Endothelial Function
|
N/A | |
Completed |
NCT04065893 -
Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
|
||
Completed |
NCT02223403 -
Effect of Nitrate-rich Beetroot Juice on Exercise Performance in Heart Failure Patients
|
N/A | |
Completed |
NCT02946853 -
Junctional AV Ablation in CRT-D: JAVA-CRT
|
N/A | |
Completed |
NCT00833352 -
Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
|
N/A | |
Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|
||
Enrolling by invitation |
NCT03984591 -
A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
|
Phase 4 | |
Completed |
NCT02156583 -
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
|
||
Recruiting |
NCT01566344 -
Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes
|
N/A | |
Withdrawn |
NCT01127334 -
Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device
|
N/A | |
Completed |
NCT03534297 -
Study of Dapansutrile Capsules in Heart Failure
|
Phase 1 | |
Completed |
NCT01765400 -
Platelet Inhibition in Patients With Systolic Heart Failure
|
Phase 4 | |
Completed |
NCT01814319 -
Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
|
Phase 2 | |
Recruiting |
NCT02637167 -
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
|
Phase 2 | |
Suspended |
NCT03755570 -
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
|
||
Completed |
NCT02084992 -
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
|
N/A | |
Completed |
NCT04937790 -
Effects of Postural Balance Exercises in Patients With Heart Failure
|
N/A |